Description

.Beta.-D-Ribo-4-Nonulopyranose, 4,9-Anhydro-1,2,3,6-Tetradeoxy-5-o-Methyl-7-o-(Phenylmethyl)- is a high-purity, advanced pharmaceutical intermediate characterized by its complex, modified sugar structure. This compound is of significant value in the synthesis of novel nucleoside analogs and other bioactive molecules, where its unique stereochemistry serves as a critical building block. It is primarily required by research institutions and pharmaceutical companies engaged in the development of antiviral agents, anticancer therapeutics, and other specialized fine chemicals.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of novel antiviral and anticancer nucleoside drugs.
• Organic Synthesis Building Block: Used in complex multi-step syntheses to introduce specific sugar moieties into target molecules.
• Biochemical Research: Employed in enzymatic studies and as a substrate analog to investigate carbohydrate metabolism pathways.
• Glycochemistry: Serves as a precursor for the synthesis of modified carbohydrates and glycomimetics with potential therapeutic applications.
• Process Development: Used in scaling up synthetic routes for active pharmaceutical ingredients (APIs) in pre-clinical and clinical stages.

Basic Information

Product Name	.Beta.-D-Ribo-4-Nonulopyranose, 4,9-Anhydro-1,2,3,6-Tetradeoxy-5-o-Methyl-7-o-(Phenylmethyl)-
CAS No.	112339-12-5
Molecular Formula	C₁₇H₂₂O₅
Molecular Weight	306.36 g/mol
Synonyms	4,9-Anhydro-1,2,3,6-tetradeoxy-5-O-methyl-7-O-benzyl-β-D-ribo-non-4-enulopyranose; 7-O-Benzyl-4,9-anhydro-1,2,3,6-tetradeoxy-5-O-methyl-β-D-ribo-non-4-enulopyranose; Benzyl 4,9-anhydro-1,2,3,6-tetradeoxy-5-O-methyl-β-D-ribo-non-4-enulopyranosid-7-urate; Modified D-Ribo-nonulopyranose derivative; Anhydro tetradeoxy methyl benzyl ribo-nonulopyranose
EINECS	Contact for details

Quality Control

Every batch of .Beta.-D-Ribo-4-Nonulopyranose, 4,9-Anhydro-1,2,3,6-Tetradeoxy-5-o-Methyl-7-o-(Phenylmethyl)- is manufactured and tested under a strict quality management system. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency meet the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic; therefore, containers should be kept tightly sealed in a dry environment to prevent moisture uptake.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.